73 related articles for article (PubMed ID: 21910336)
21. [Significance of pelvic lymph node human papillomavirus DNA detection in cervical cancer].
Liu GB; Liu X; Pang ZJ; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1236-9. PubMed ID: 16234097
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME; Dalbert D; Picconi MA; Cúneo N; González J; Vornetti S; Bazán G; Mural J; Basiletti J; Teyssié AR; Alonio LV
J Med Virol; 2008 Apr; 80(4):694-701. PubMed ID: 18297710
[TBL] [Abstract][Full Text] [Related]
23. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
24. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
25. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy.
Wang CC; Lai CH; Huang HJ; Chao A; Chang CJ; Chang TC; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1111-20. PubMed ID: 20231068
[TBL] [Abstract][Full Text] [Related]
26. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
27. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
Onal C; Guler OC; Reyhan M; Yapar AF
Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567
[TBL] [Abstract][Full Text] [Related]
30. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
Gold MA; Tian C; Whitney CW; Rose PG; Lanciano R
Cancer; 2008 May; 112(9):1954-63. PubMed ID: 18338811
[TBL] [Abstract][Full Text] [Related]
31. Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer.
Takeshita S; Kita T; Motoike Y; Umezawa K; Sugisaki S; Matsumoto S; Matsumoto Y; Ryo E; Ayabe T
J Obstet Gynaecol Res; 2010 Oct; 36(5):1009-14. PubMed ID: 20722988
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
33. Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastases.
Lai CH; Tang SG; Chang TC; Tseng CJ; Chou HH; Huang KG; Hsueh S; Hong JH; Huang SL; Lin JD; Soong YK
Changgeng Yi Xue Za Zhi; 1998 Sep; 21(3):291-9. PubMed ID: 9849010
[TBL] [Abstract][Full Text] [Related]
34. [Effect of ruji recipe on the post-surgical survival of female breast cancer patients].
Tian HQ; Wang YJ; Wang B; Huang YL; Li HL; Huang XQ; Zhang XC; Yang YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1336-40. PubMed ID: 24432675
[TBL] [Abstract][Full Text] [Related]
35. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
[TBL] [Abstract][Full Text] [Related]
36. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
37. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
38. [Effect of preoperative chemotherapy on bulky cervical cancer by internal iliac arterial infusion].
Chen YL; He GQ; Wang ED
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):231-4. PubMed ID: 15924667
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
40. [Follow-up of high risk, human papillomavirus (HPV)-positive patients with cancer of the uterine cervix].
Hernádi Z; Sápy T; Kónya J; Veress G; Czeglédy J
Orv Hetil; 1997 May; 138(20):1249-53. PubMed ID: 9244858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
